A phase I study to characterize the safety, tolerability, and pharmacokinetics of topotecan at 4 mg/m2 administered weekly as a 30-minute intravenous infusion in patients with cancer.
J Clin Pharmacol
; 50(3): 268-75, 2010 Mar.
Article
en En
| MEDLINE
| ID: mdl-19808951
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Topotecan
/
Tolerancia a Medicamentos
/
Neoplasias
/
Antineoplásicos
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Clin Pharmacol
Año:
2010
Tipo del documento:
Article
País de afiliación:
Estados Unidos